Last updated on February 2019

A Multicenter Feasibility Study of DyeVert Plus™ Contrast Reduction System Use to Reduce Contrast Media Volumes in Angiography Procedures Using Optical Coherence Tomography Dyevert

Brief description of study

The purpose of this post-market feasibility study is to evaluate whether DyeVert Plus Contrast Reduction System use during standard angiography procedures involving the use of OCT result in contrast media (CM) volume savings without reducing image quality.

The primary objective of this study is to evaluate the volume (percentage) of CM saved over the total procedure, during manual injection.

The secondary objective of this study is to evaluate image quality.

Clinical Study Identifier: TX208022

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.